Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Dec 28;145(5):1406–1415. doi: 10.1016/j.jaci.2019.11.047

Figure 2. Molecular profiling for AD progression from acute to chronic.

Figure 2

a) effect size in the acute vs chronic AD comparison for genes dysregulated in non-lesional vs. acute AD; b) effect size comparison between non-lesional vs. acute AD (x-axis) against acute AD vs. chronic AD (y-axis). Genes are colored if they are dysregulated in the first (blue), second (red) or both comparisons (purple); c-d) boxplots to illustrate the expression profiles for 2 genes dysregulated in the acute vs. chronic comparison but not in the non-lesional vs. acute comparison.